Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation

Author:

Kang Han Na,Choi Jae Woo,Shim Hyo SupORCID,Kim Jinna,Kim Dae Joon,Lee Chang Young,Hong Min HeeORCID,Park Seong Yong,Park A-Young,Shin Eun Joo,Lee Seo Yoon,Pyo Kyoung-Ho,Yun Mi Ran,Choi Hun Mi,Lee Sung Sook,Kim Seok-Young,Lee Hanna,Paik SoonmyungORCID,Cho Byoung Chul,Lee Jin GuORCID,Kim Hye Ryun

Funder

Korea Health Technology R&D Project

Ministry of Health & Welfare, Republic of Korea

Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)

Ministry of Health &Welfare, Republic of Korea

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference37 articles.

1. Current status of research and treatment for non-small cell lung cancer in never-smoking females;Saito;Cancer Biol. Ther.,2017

2. Advances in chemotherapy in advanced non-small-cell lung cancer;Maione;Expert Opin. Pharmacother.,2010

3. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer;Kwak;N. Engl. J. Med.,2010

4. Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers;Fichtner;Clin. Cancer Res.,2008

5. Human tumor xenografts: predictivity, characterization and discovery of new anticancer agents;Fiebig,1999

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3